Items tagged with HIV coinfection
Hepatitis B or raised liver enzymes predict liver toxicity when TB prevention drug is combined with HIV treatment (post)
The risk of liver toxicity in people with HIV taking antiretroviral therapy and isoniazid preventive therapy for tuberculosis is strongly associated with either hepatitis B co-infection or pre-existing liver enzyme elevations, according to international research published in the 1 May edition of the Journal of Acquired Immune Deficiency Syndromes.
Price cut on medicine will help preserve the health of more people living with HIV (post)
Geneva, 08 June 2018 — Unitaid and Indian drug manufacturer Cipla Ltd. struck a landmark agreement today that will lower the price of the first combination therapy (containing co-trimoxazole, isoniazid and vitamin B6) that prevents opportunistic infections in people living with HIV.
High rates of HIV and diabetes raise the risk of TB for South Africans (post)
Since the 1980s, HIV has contributed to an increase in tuberculosis (TB) cases across the globe. Recently, diabetes has been found to be an important risk factor for TB. In a new study, Yale researchers investigated whether having both HIV and diabetes increases the risk of developing TB among individuals living in rural South Africa.
Webinar: Results from ACTG 5279/BRIEF-TB trial (post)
Have you heard?? ACTG 5279: One-month TB prophylaxis as effective as nine-month regimen for people living with HIV
At AIDS 2018, advocates want action from world leaders to end TB-HIV (post)
Amsterdam, The Netherlands (July 23, 2018) — In preparation for the first ever United Nation’s High-Level Meeting (UNHLM) on tuberculosis (TB), to be held September 26, in New York, advocates are calling on the HIV/AIDS community to use the 22nd International AIDS Conference to draw attention to the deadly link between TB and HIV. The conference, which runs from July 23 to 27, is the last major gathering of both the TB and HIV advocacy communities before the highly anticipated UNHLM on TB. Scores of delegates from across the world are here for the conference.
HIV-TB connection: key to ending infections (post)
- A group of teenage boys huddle around Michelle in the mangroves behind Joyce Bay, a spot frequented by men who have sex with men (MSM) in Port Moresby, Papua New Guinea (PNG).
The TB and HIV co-epidemic in the spotlight at the 22nd International AIDS Conference (post)
22 July 2018 | AMSTERDAM: The TB and HIV co-epidemic was in the spotlight at the 22nd International AIDS Conference, “Breaking Barriers, Building Bridges”, which took place in Amsterdam, the Netherlands and was attended by more than 15,000 delegates. The World Health Organization delegation was led by the Director-General, Dr. Tedros Adhanom Ghebreyesus who opened the conference calling on delegates to harness the same energy and passion, and the same resources used to respond to HIV, in order to achieve universal health coverage, asserting that this is how we will defeat AIDS and build a healthier safer world for everyone, everywhere. This message is also essential for ending TB and ensuring people-centred care and prevention for all.
Use of Xpert TB diagnostic tool linked to lower death rates from all causes among HIV patients entering care in Malawi study (post)
Study randomized clinics to use Xpert or fluorescence microscopy for patients newly diagnosed with HIV showing TB symptom.
Study shows children with multidrug-resistant TB can be treated (post)
The results of a large, international systematic review published in the journal PLOS Medicine show that tuberculosis treatment is successful in children with multidrug-resistant tuberculosis (MDR-TB). The study was used to inform the World Health Organization guidelines on treatment of MDR-TB in children.
Yale, South African researchers partner to prevent and treat HIV and TB (post)
Former South African president Nelson Mandela once emphasized that the war against AIDS could not be won without confronting the country’s tuberculosis epidemic. For the last 16 years, a group of Yale researchers in the Yale AIDS Program has been doing just that through their involvement in the Tugela Ferry Care and Research Collaboration (TF CARES), an international non-governmental organization committed to improving prevention, care, and treatment for adults and children with HIV/AIDS and tuberculosis through clinical care, research and capacity building in Tugela Ferry, South Africa.
Page 27 of 52 · Total posts: 0
←First 26 27 28 Last→